2022
Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries
Worsley-Tonks KEL, Bender JB, Deem SL, Ferguson AW, Fèvre EM, Martins DJ, Muloi DM, Murray S, Mutinda M, Ogada D, Omondi GP, Prasad S, Wild H, Zimmerman DM, Hassell JM. Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries. The Lancet Global Health 2022, 10: e579-e584. PMID: 35303467, PMCID: PMC8923676, DOI: 10.1016/s2214-109x(22)00031-6.Peer-Reviewed Original ResearchConceptsMiddle-income countriesDisease surveillanceGlobal health securityNational surveillance systemRural areasHealth securityRemote rural areasRoutine exposureHealth careZoonotic diseaseCOVID-19 pandemicSurveillanceZoonotic disease surveillanceSurveillance effortsFrequent contactSurveillance systemRural communitiesEvaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics
Yaesoubi R, Cohen T, Hsu K, Gift TL, St. Cyr SB, Salomon JA, Grad YH. Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLOS Computational Biology 2022, 18: e1009842. PMID: 35139073, PMCID: PMC8863219, DOI: 10.1371/journal.pcbi.1009842.Peer-Reviewed Original ResearchConceptsIncidence of gonorrhoeaTreatment guidelinesResistance prevalenceGonorrhea casesTreatment of gonorrheaNational surveillance systemPrevalence of resistanceTransmission dynamic modelGonococcal infectionGonorrhea treatmentMSM populationAntibiotic susceptibilityGonorrheaStandardized guidelinesSurveillance dataPrevalenceIncidenceAntibioticsPotential strategySurveillance systemAbsence of pointsGuidelinesCurrent strategiesEffective lifespanMen
2014
Cutaneous leishmaniasis in Mullaitivu, Sri Lanka: a missing endemic district in the leishmaniasis surveillance system
Semage SN, Pathirana KP, Agampodi SB. Cutaneous leishmaniasis in Mullaitivu, Sri Lanka: a missing endemic district in the leishmaniasis surveillance system. International Journal Of Infectious Diseases 2014, 25: 53-55. PMID: 24858902, DOI: 10.1016/j.ijid.2014.03.1382.Peer-Reviewed Original ResearchConceptsCutaneous leishmaniasisArmed Forces personnelCumulative annual incidencePublic health surveillance systemsNational surveillance systemSurveillance systemPublic health threatHealth surveillance systemsTime of investigationSri Lanka ArmyAnnual incidenceEndemic districtsEpidemic proportionsReported casesArmy populationLeishmaniasisHealth threatIncidenceDisease surveillanceControl activitiesUrgent attentionSri LankaLesionsMullaitivu
2013
Validation of the surveillance and reporting of central line-associated bloodstream infection denominator data
Backman LA, Nobert G, Melchreit R, Fekieta R, Dembry LM. Validation of the surveillance and reporting of central line-associated bloodstream infection denominator data. American Journal Of Infection Control 2013, 42: 28-33. PMID: 24176605, DOI: 10.1016/j.ajic.2013.06.014.Peer-Reviewed Original ResearchConceptsDenominator dataBlinded retrospective chart reviewCentral line-associated infectionsLine-associated infectionsRetrospective chart reviewAcute care hospitalsNational surveillance systemComparison of hospitalSignificant differencesChart reviewCare hospitalPatient chartsHospitalInternal validationConnecticut DepartmentPublic healthSurveillance systemCountCLDStrict definitionDaysReportingInfection
2012
Data mining methodologies for pharmacovigilance
Liu M, Matheny M, Hu Y, Xu H. Data mining methodologies for pharmacovigilance. ACM SIGKDD Explorations Newsletter 2012, 14: 35-42. DOI: 10.1145/2408736.2408742.Peer-Reviewed Original ResearchAdverse drug reactionsElectronic medical recordsLong-term adverse drug reactionsTerm adverse drug reactionPrevention of ADRsAdverse drug eventsPatient-reported dataPotential adverse drug reactionsNational surveillance systemEmergency departmentDrug eventsDrug reactionsPreclinical dataMedical recordsADR monitoringClinical trialsMedication safetyPreclinical characteristicsSpontaneous reportsPostmarketing phaseOnline health forumsPostmarketing stageDrug developmentHealth forumsPre-marketing stagesU.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals Of Internal Medicine 2012, 157: 325-35. PMID: 22944874, PMCID: PMC3534765, DOI: 10.7326/0003-4819-157-5-201209040-00005.Peer-Reviewed Original ResearchConceptsCD4 cell countCD4 T-lymphocyte cell countMedian CD4 cell countT-lymphocyte cell countAntiretroviral therapy useHIV VLCell countNA-ACCORDHIV RNATherapy useViral loadU.S. National HIV/AIDS StrategyHealth outcomesNational HIV/AIDS StrategyCanadian HIV Trials NetworkHIV/AIDS StrategyActive antiretroviral therapyHIV outpatient clinicAnnual cross-sectional analysesHIV Cohort StudyProportion of participantsNational surveillance systemRelated health outcomesSimilar demographic characteristicsCross-sectional analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply